ReviewGlobal cardiology science & practice2021
Cardiovascular adverse events in pregnancy: A global perspective.
Review in Global cardiology science & practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Contemporary approaches to extracorporeal membrane oxygenation usage in extended peripartum period over a decade - a systematic review.BMC pregnancy and childbirth · 2026Pooled it
- Maternal Mortality and Cardio-Kidney-Metabolic Risk Factors Across High-Income Countries.JACC. Advances · 2026Article
- Maternal Cardiovascular Emergencies During Pregnancy and the Puerperium: Current Diagnostic Approach and Management.Medicina (Kaunas, Lithuania) · 2026Review
- Impact of Cardiac Arrhythmias on Acute Maternal Cardiovascular Outcomes in Pregnancy: A Systematic Review and Meta-Analysis.Life (Basel, Switzerland) · 2026Review
- [ESC Guidelines on cardiovascular diseases and pregnancy-most important facts of the 2025 update].Herz · 2026Review
- Sensitivity of Administrative Coding for Heart Disease in Pregnancy.Clinical epidemiology · 2026Article
- Article
- Implementation of a national rheumatic fever and rheumatic heart disease prevention and control program in Egypt: rationale and objectives.Frontiers in cardiovascular medicine · 2026Article
- The "Cairo Accord"- towards the eradication of RHD: revisited (2026).Frontiers in cardiovascular medicine · 2026Review
- Radical Healing Approaches For Black Maternal Health: A Critical Review.Journal of racial and ethnic health disparities · 2025Review
- Increase of augmentation index (AIx@75): a promising tool for screening hypertensive pregnancy disorders.BMC pregnancy and childbirth · 2025Article
- Anesthetic Management of a Pregnant Patient With Mixed Aortic Valve Disease Undergoing Cesarean Section.Cureus · 2025Article
- Dynamic change in maternal cardiac function during pregnancy.Frontiers in cardiovascular medicine · 2025Article
- Cardio-Obstetrics Practice in Latin America: A Regional Survey of General Cardiologists.JACC. Advances · 2024Article
- Pre-existing maternal cardiovascular disease and the risk of offspring cardiovascular disease from infancy to early adulthood.European heart journal · 2024Article
- Early- to mid-gestational testosterone excess leads to adverse cardiac outcomes in postpartum sheep.American journal of physiology. Heart and circulatory physiology · 2024Article
- Article
- Association of pre-existing maternal cardiovascular diseases with neurodevelopmental disorders in offspring: a cohort study in Sweden and British Columbia, Canada.International journal of epidemiology · 2024Article
- Maternal left ventricular function and adverse neonatal outcomes in women with cardiac disease.Archives of gynecology and obstetrics · 2023Article
- Impact of Adverse Gestational Milieu on Maternal Cardiovascular Health.Endocrinology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pregnant women with heart disease are vulnerable to many adverse cardiovascular events (AE). AEs during and after pregnancy continue to be important causes of maternal mortality and morbidity worldwide, with huge variations in burden in different countries and regions. These AEs are classified as having direct or indirect causes, depending on whether they are directly caused by pregnancy or due to some pre-existing disease and/or non-obstetric cause, respectively. The risks continue throughout pregnancy and even after childbirth. Apart from immediate complications during pregnancy, there is increasing evidence of a significant link between several events and the risk of cardiovascular disease (CVD) later in life. A significant number of pregnancy-related deaths caused by cardiovascular disease are preventable. This prevention can be realized through increasing awareness of cardiovascular AE in pregnancy, coupled with the application of strategies for prevention and treatment. Knowledge of the risks associated with CVD and pregnancy is of extreme importance in that regard. We discuss the global distribution of cardiovascular maternal mortality, adverse events during and after pregnancy, their predictors and risk stratification. In addition, we enumerate possible solutions, particularly the role of cardio-obstetric clinics.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.